Get Connected:

Atrial Fibrillation
The MD Magazine Atrial Fibrillation condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Positive Outcomes Following Left Atrial Appendage Closure with Amplatzer Plug in High-Risk Patients with Atrial Fibrillation
Retrospective analysis of real-world outcomes supports the use of the Amplatzer cardiac plug for left atrial appendage closure in atrial fibrillation patients with a very high risk of stroke or serious bleeds and who cannot tolerate oral anticoagulation.
Study results suggest that gout itself and not hyperuricemia alone is associated with left ventricular diastolic dysfunction and left atrial volume enlargement.
When patients have a defibrillator implated they have many concerns about their overall health, including how it affects their sex life. Research has shown the importance of doctors and their patients working together through these issues.
While warfarin has long been a common treatment option for patients with atrial fibrillation new medications are coming to the market which provide different benefits than the original option.
Analyses of patient records indicate that obesity increases the risk of recurrence among patients who undergo ablation for atrial fibrillation but suggest that sustained weight loss can reduce the risk.
Injecting globs of a biopolymer based on brown algae into the heart muscle of patients with advanced heart disease helped halt or reverse disease. The procedure is meant to thicken the ventricle wall. That reduces pumping stress.
An investigational drug called andexanet alfa that can reverse the anticoagulant effects of FXa inhibitors met all primary and secondary efficacy endpoints, researchers said in a late-breaking clinical trial report at the AHA meeting in Orlando.

Most Popular

$vacMongoViewPlus$ $vAR$